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Volume 52, Number 3 Abstracts 80723 mm (OR, 2.96; 95% CI, 1.74-5.03), and a proximal neck length 22
mm (OR, 2.41; 95% CI, 1.42-4.10).
Conclusion: In this series, TSR was accurately predictive of a
durable success after EVAR. It occurred mostly in patients with a
favorable anatomy. Less intensive follow-up work-up seems to be safe in
patients with TSR.
Synchronous and Metachronous Thoracic Aneurysms (TAA) in Pa-
tients With Abdominal Aortic Aneurysms (AAA)
Rabih A. Chaer, MD, Rogerio Vasconcelos, MD, Jae Cho, MD, Robert
Rhee, MD, Luke Marone, MD, and Michel Makaroun, MD, UPMC,
Pittsburgh, Pa
Objectives: Although the association of TAA with AAA is known, the
exact incidence has not been described. Our goal was to quantify the
incidence of TAA in patients with an AAA and assess predictive factors for its
diagnosis.
Methods: This was a retrospective review of patients with AAA from
2000-2008. Univariate and logistic regression analyses of TAA predictors
were performed.
Results: We reviewed 2196 patients with an AAA, of which 1082
(49%) had a chest CT during follow-up. TAA was synchronous in 117
patients (10.8%) and metachronous in 136 (12.6%). Mean time to
diagnosis was 2.3 years. Mean diameter was 4.74 1.43 cm for AAA and
4.70  1.03 for TAA. Indications for the chest CT were variable. Most
common were AAA (15%), pulmonary embolus (14%), and lung cancer
(11%). Only 38% of AAAs and 14% of TAAs were repaired during the
study period. At a mean follow-up of 43.6 months, there were 79 deaths
(7%): 7 were AAA-related, and 13 died of TAA ruptures. Univariate
associations of AAA and TAA are described in the Table. Predictors of
TAA diagnosis by logistic regression include black race (OR, 1.8; P 
.02), family history of TAA (OR, 7.6; P  .04), hypertension (OR, 1.7;
P  .006), and obesity (OR, 1.7; P  .006). Diabetes, infrarenal AAA
location, and smoking have a negative association.
Conclusions: TAAs are quite common in patients with AAA. Routine
or targeted screening with a chest CT at the time of AAA diagnosis may be
indicated.
Type I Endoleak: Impact of Graft Selection and Anatomic Factors
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Objectives: This study aimed to assess the impact of anatomic and
aortic endovascular graft characteristics on the occurrence of type 1 endoleak
after endovascular abdominal aortic aneurysm repair (EVAR).
Methods: A prospective database encompassing all patients treated
with EVAR between 2001 and 2009 was established and categorized based
on presence of endoleak. All patients were followed-up clinically and with
duplex imaging or CTA at 1, 6, and 12 months and yearly thereafter.
Preoperative anatomic and clinical variables were correlated with presence of
endoleak. Statistical analysis was performed using the independent-sample t
test and 2 tests as appropriate.Results: A total of 388 patients (75% male) with a mean age of 76.5
years (range, 42-96 years) underwent EVAR. Of these, 28 (7.2%) were
identified with postoperative type I endoleak (22 type Ia, 4 type Ib, and 2
combined Ia, Ib). The mean follow-up was 29 months (range, 1-98
months). Mean time to the detection of endoleak was 11.6 1.2 months
(range, 1-45 months). Two groups (type I endoleak vs no endoleak) were
similar regarding demographics and comorbidities, except for significantly
higher mean age, higher PVD, and lower smoking history in the type I
endoleak group. Primary factors associated with type I endoleak were
aneurysm size 63 mm (P  .001), age 80 (P  .027), shorter neck
length 15 mm (P  .005), reverse funnel neck configuration, infrarenal
stent fixation 14.6 mm (P  .006), and short distal iliac fixation (¾ of
common iliac length; P .05). Freedom from type I endoleak by graft type
was Zenith, 97.3%; Talent, 84.6%; Excluder, 100%; and AneuRx, 89%.Mean
aneurysm rupture-free period was 27.95 16months. Twenty-four patients
(86%) with type I endoleak underwent initial EVAR to seal the leak, with
83.4% success rate. Four patients (14%) required more than one reinterven-
tion to fix the endoleak. Seven patients (25%) required explant and conver-
sion to open repair. Overall mortality in type I endoleak group was 10.7% (3
of 28 all secondary to rupture).
Conclusion: The etiology of type I endoleak is multifactorial and
careful patient and graft selection is critical to reduce this potentially lethal
complication.
Anatomic predictors of type I endoleak
Variable No endoleak Type I endoleak P
Age 76.5  8.16 80  6.67 .027a
Max AAA diameter, mm 56.4  11.13 63.84  12.2 .001a
Prox neck diameter, mm 26.39  13.6 26.2  4.03 .951a
Neck length, mm 27.3  24 14.4  9.0 .005a
Neck configuration
(reverse funnel), No.
(%)
116 (32.3) 22 (78.6) .001b
Infrarenal stent fix, mm 27.8  24.8 14.6  9.0 .006a
Suprarenal stent fix, mm 13.6  8.1 10.6  6.8 .104a
Right iliac fixation, % 81.0 71.2 .007a
Left iliac fixation, % 81.1 71.5 .013a
aIndependent-sample t test; b2.
Outcome of Elective Endovascular Abdominal Aortic AneurysmRepair
in Nonagenarians
Stuart B. Prenner, BS, Irene C. Turnbull, MD, Gregory W. Serrao, BS,
Maggie Walkup, MD, Eric Fishman, MD, Sharif H. Ellozy, MD, Ageliki G.
Vouyouka, MD, Michael L. Marin, MD, and Peter L. Faries, MD, Mount
Sinai School of Medicine, New York, NY
Objective: Compared with open repair of abdominal aortic aneurysms
(AAA), endovascular repair (EVAR) is associated with decreased periopera-
tive morbidity and mortality in a standard patient population. This study
sought to determine if the advantage of EVAR extends to patients aged90
years.
Methods: This was a retrospective review from a prospectively main-
tained computerized database. Of the 1270 patients treated with EVAR
from January 1997 toNovember 2007, 24 (1.9%) were aged90.Mean age
was 91.5  1.5 years (range, 90-95 years), and 83.3% were male. Mean
aneurysm size was 6.8 cm (range, 5.2-8.7 cm; Table).
Results: Mean procedural blood loss was 490 mL (range, 100-4150
mL), and 20.8% required an intraoperative transfusion. Mean postoperative
length of stay was 6.0 days, (median, 4 days; mode, 1 day; range, 1-42 days),
with 33.3% of patients discharged on the first postoperative day. There were
six (25.0%) perioperative major adverse events and a perioperative mortality
rate of 8.3% (2 of 24). Mean follow-up was 20.5 months (range, 1-49
months). Overall, three patients (12.5%) required secondary intervention
(thrombectomy, angioplasty, and proximal cuff extension). No patients
required conversion to open repair, and two patients (8.3%) died of AAA
rupture at 42 and 517 days after EVAR. Freedom from all-cause mortality at
1 year was 80.9%. Freedom from aneurysm-related mortality at 5 years was
69.5% (Fig). Endoleak occurred in 6 patients (25.0%), with 3 type I, 1 type
II, and 2 of indeterminate type; of these, 2 patients with type I endoleak
underwent secondary intervention (153 and 489 days after EVAR), of which
one case was successful.
Conclusion: Our study supports that EVAR in nonagenarians is asso-
ciated with high procedural success and acceptable perioperative morbidity
and mortality. The midterm results support the use of EVAR in carefully
selected patients  90 years old.
